CMTR-CHEMTRAK FDA OK Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CMTR-CHEMTRAK FDA OK

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Art Baer who wrote (581)	4/1/1997 3:12:00 PM
From: William Presti	of 1172

Art, I saw the press release too and wondered why it was released that way. Wouldn't this sort of restatement normally just get filed with the SEC? Maybe Ed is in fact doing exactly what he told me he would do and that is keeping the investors (or potential ones) as informed as possible. Too bad it was a revision downwards, but that's all history now. We have, as a group been pretty good about not going overboard with speculation. But now that the quarter has ended maybe we can muster up some educated guesses as to what the quarter will look like. My guess is that whatever the revenue will be for the quarter it will be measured against expenses somewhere around 2.5 million. I speculated earlier that revenues from Cholestrak would be about .5 million. Who knows about Colocare. Let's say half that - .25 million. And milestone payments of about a million between Astra Merck and Selfcare. So total it up and I would say we could be looking at a 1.75 million quarter on the high side and 1.25 million on the low side. This would be ROUGHLY 1 million in the whole for the quarter. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next